Clinical Trial Update: Study of Iguratimod in Sjögren's Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describes a Phase 1/Phase 2 study of iguratimod for Sjögren's syndrome, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren's Syndrome | Phase 1, Phase 2 | Status: UNKNOWN